



Geneticists are making headlines almost
daily as they decode the human genome.
By the year 2005, it is expected that
researchers will have most of the sequence
data in hand. Yet genes are proving time
and again to be only part of the complex
disease picture, as many common diseases
such as cancer, Alzheimer's disease, osteo-
porosis, and asthma are being shown to
have crucial environmental elements.
Now the NIEHS is launching a $60
million Environmental Genome Project to
elucidate the intricate interactions between
genes and environment. Relying heavily on
technology developed by the Human
Genome Project, the Environmental
Genome Project seeks to determine genetic
sequence diversity data for the U.S. popu-
lation on more than 200 genes known to
control susceptibility to environmentally
linked diseases, and to develop a central
database ofpolymorphisms for these genes.
Then, on the basis ofsubsequent epidemi-
ological studies, extramural researchers at
centers nationwide will determine how the
polymorphisms account for increased risk
ofor resistance to disease upon exposure to
specific toxins or carcinogens. In addition,
the project will look at environmental fac-
tors ranging from diet (including what
people eat and how they prepare food) to
effects of exposure to chemical mixtures,
which is another NIEHS priority.
"This is very different [from] the
Human Genome Project, which is much
more focused on disease genes," says Karl
Kelsey, a molecular epidemiologist at
Harvard University. "This will enable us to
develop better intervention strategies for
individuals and populations," Kelsey says.
Disease prevention is more complex
than just targeting genes. Few diseases are
the consequence ofa single genetic or envi-
ronmental event, says NIEHS Director
Kenneth Olden. For example, only a small
percentage ofall cancer cases can be attrib-
uted to a single defective or mutant gene,
typically identified from familial clusters of
disease. Instead, common allelic variants of
susceptibility genes with relatively low pen-
etrance account for a higher percentage of
cancers and other chronic diseases overall.
Thus, properly controlling environmental,
occupational, or lifestyle exposures could
prevent more diseases than just those
caused by rare, highly penetrant alleles that
lead to familial clusters, explains Jack
Taylor, head ofthe NIEHS molecular and
genetic epidemiology group.
To get a more accurate picture of risk
from exposures, researchers need to under-
stand the nature, significance, and distribu-
tion ofsusceptible genotypes in the general
population, NIEHS officials contend.
Molecular and genetic techniques
advanced by the Human Genome Project
now make possible studies of individual
differences in susceptibility to diseases and
dysfunction linked to environmental expo-
sure. It is hoped that the Environmental
Genome Project and the Human Genome
Project will complement each other, Olden
says. "We can take advantage of and build
on what [the] other is doing."
Information gleaned from the
Environmental Genome Project could
refine current risk assessment capabilities
to better protect sensitive subgroups such
as children or people who are immuno-
compromised, and to potentially reduce
regulatory costs. Although today's risk
assessments and resulting chemical regula-
tions do a pretty good job given the data
that are available, "they make the assump-
tion that there is an average individual and
an average exposure," Olden says. "There
may be an average exposure, but not an
average individual." As it stands, he con-
tinues, "whether we're actually protecting
the health ofthe American people is uncer-
tain. We may be underregulating or over-
regulating," as the deviation from the
norm can be enormous.
Variances in the responsiveness to
exposures caused by susceptibility genes
have made the definition ofenvironmental
disease components difficult. The
Environmental Genome Project may shed
light, for example, on disease caused by
exposure to the nerve gas sarin or other
organophosphates used during the Persian
GulfWar, Olden says. People with certain
polymorphisms produce variants of the
enzyme paraoxonase that have difficulty
breaking down such nerve agents and relat-
ed pesticides while people with other allelic
variations are more resistant to disease.
"The project has tremendous public
health implications and will have a tremen-
dous public health impact," Olden says. "If
we can understand how these agents inter-
act, we'll be in much better shape to pre-
vent and not just treat end-stage diseases."
Project researchers anticipate collecting
blood samples from approximately 1,000
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Americans from five ethnic groups-Asian
American, African American, Hispanic,
Caucasian, and Native American-in order
to learn what the allelic variations and fre-
quencies of these "environmental disease"
genes are in the U.S. population overall and
within ethnic groups. Exons and regulatory
regions of these genes from different age
groups will also be sequenced to studygenet-
ic variability. "Getting the proper informed
consent is important," Taylor adds, "because
this group ofsamples will become a national
resource for future studies."
To date, only a handful ofsusceptibili-
ty genes have been explored for genetic
polymorphisms, Taylor says. For instance,
some alleles may increase risk for one dis-
ease and decrease the risk for another dis-
ease, while other alleles only increase the
risk of disease if a person has an environ-
mental exposure.
Currently, more than 200 candidate
genes are under consideration for the core
study from five broad classes: genes con-
trolling the distribution and metabolism of
toxicants, genes for the DNA repair path-
ways, genes for the cell cycle/cell death
control system including apoptosis, genes
for metabolism of nucleic acid precursors,
and genes for signal transduction systems
controlling expression ofthe genes in other
classes. Olden plans to convene a confer-
ence in the early fall of about 30 key
geneticists, epidemiologists, and policy
makers to determine which genes should
be included in the project and to establish
a study group to provide peer review for all
aspects ofthe project. Researchers from six
DNA sequencing centers selected through
NIEHS Director Receives Inaugural NAPE Award
On May 23, the National Association of Physicians for the
Environment (NAPE) presented its inaugural award for public
policy leadership in protecting health and the environment to
Kenneth Olden, director ofthe NIEHS. John Grupenhoff, execu-
tive vice president ofthe NAPE, said that Olden's dedication and
leadership had advanced the 1,000-employee institute to new
prominence and had brought environmental health to the fore-
front of public concern. "He's putting environmental health on
the map . . . and that's something we wanted to recognize him
for," Grupenhoffsaid.
Olden was chosen as the third director ofthe NIEHS and the
second director of the National Toxicology Program (NTP) on
18 June 1991. Since that time, the institute has grown in size and
reputation, improving its intramural research programs and sup-
porting extramural environmental
health science centers at universities
across the nation.
Olden said that one important
change he has made since becoming
NIEHS director has been to increase
the institute's emphasis on human
health. "In the past," Olden explained,
"the public knew us more for our
toxicology work and animal studies.
The public didn't understand that
the work we do here is relevant to
human diseases like osteoporosis [and]
Parkinson's disease. But, in reality,
almost all diseases have an environ-
mental component. I've tried to focus
the institute on human diseases and
the preventive measures related to the
environment that can be taken to pro-
tect human health. . . . I want the
NIEHS to be known as the institute of
theNIH that focuses on prevention."
The NAPE also noted that the
NIEHS and the NTP maintain their
position at the forefront ofresearch in
the field by continuously undertaking
bold new projects. Recently, Olden
announced the institute's plan to map
the "environmental genome" to deter-
mine how heredity affects a person's
susceptibility to environmental insults. Another new project will
use large-scale blood and urine testing to determine pollutant lev-
els in U.S. residents.
However, Grupenhoff said, one of the most important
accomplishments ofthe NIEHS under Director Olden is the new
communications channels that have been forged between the
institute and others who are concerned with environmental
health. "Immediately upon becoming director of the institute,
Ken Olden began a dialogue with representatives ofprofessional
and scientific organizations, with industry groups, with environ-
mental advocacy groups, with labor unions, andwith economical-
lydisadvantaged groups who suffer the preponderance ofenviron-
mental exposures," Grupenhoff noted in a press release. Said
Olden, "When I came here, I made a commitment that I was
al6
The natural choice. John Grupenhoff (left), executive vice
presidentofthe NAPE, called NIEHS director Kenneth Olden
(right) "the natural choice' forthe group's inaugural award
for public policy leadership to protectthe environment and
health.
going to make the institute responsive
to the American people. We are identi-
fying issues that people think are
important and we are doing research
that people are excited about." In this
vein, the NTP recently invited the pub-
lic to nominate substances for inclusion
in its Biennial Report on Carcinogens.
Olden said that he was very pleased
to be recognized by an organization of
health professionals and that he looks
forward to a prosperous relationship
between the NIEHS and the NAPE.
"This award further elevates the insti-
tute to a leadership role and increases
our visibility. It shows we've taken our
place among other institutes as a health
organization," he said.
The NAPE, which was formed in
1993, is the designated U.S. member of
the International Society ofDoctors for
the Environment. Its mission is todistrib-
ute information and build consensus
among health professionals on environ-
mentalissues, toactasaforumfordebate,
and to educate the public. The NAPE's
headquarters areinBethesda, Maryland.
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a competitive funding process will evaluate
polymorphisms that affect 1% or more of
the population, rather than rare mutations
that affect less than 1% ofthe population.
In addition, a center will be formed to
store and standardize the core data.
"There are many more genes than we
can test," says NIEHS researcher Douglas
Bell. Yet the list of catalogued genes and
the size of the database will likely grow
over the next decade as additional envi-
ronmental susceptibility genes are discov-
ered and related epidemiological studies
completed.
About 100 of the candidate genes are
metabolism and detoxification genes that
regulate cytochrome P450s, NATs, GSTs,
glucuronyl transferases, sulphotransferas-
es, methyltransferases, metallothioneins,
and paraoxonases. The GST genes, for
example, code for enzymes such as glu-
tathione S-transferases, which help the
body dispose of carcinogens known to be
involved with lung, brain, and bladder
cancers, among other diseases. Similarly,
variations in ADH and ALDH genes have
been linked to alcohol-related diseases,
including cancer.
There are about 50 DNA repair genes
and 50 toxicant receptor genes under con-
sideration as well. The DNA repair genes
correct mistakes that occur during DNA
matching, nucleotide excision, base exci-
sion, and recombination. Inability to
repair such mistakes can cause skin and
other cancers, Bell explains. Toxicant
receptor genes include those that modify
pathways related to toxic response, such as
Ah receptors, estrogen receptors, proges-
terone receptors, and endocrine disruptor
pathways. Variations in genes in the main
toxicology classes-neurotoxicology,
reproductive toxicology, and developmen-
tal toxicology-are also strong candidates,
Bell says.
Genes involved in nutrition pathways
or the metabolism ofnutrients such as vit-
amins and minerals account for another 25
candidates. Certain polymorphisms in
nutrient pathways contribute to diseases
such as hemochromatosis (an iron imbal-
ance), cirrhosis, and liver cancer. Steroid
metabolism genes involved in the synthesis
ofestrogen, progesterone, and testosterone
account for an additional 25 or so candi-
dates.
Olden estimates that the first phase of
the project-collecting and sequencing the
core genetic data and establishing the sam-
ple storage and distribution center-will
be completed in about five years. The sec-
ond phase ofthe project, which comprises
determining the functional significance of
the identified polymorphisms and con-
ducting population-based studies ofassoci-
ations among alleles, exposures, and dis-
ease rates through a mix ofinvestigator-ini-
tiated, extramural, and intramural
research, will overlap with the project's
first phase and probably continue into the
next decade. "Epidemiological and func-
tional studies will come on line as soon as
we have the information to do that,"
Olden says.
The third and final stage ofthe project
entails developing, on the basis ofthe new
findings, improved risk assessments and
regulations for environmental exposures,
better protections for susceptible sub-
groups, and targeted disease screening for
high-risk groups, according to NIEHS
officials. Some of these improved guide-
lines, prevention strategies, and medical
treatments can be implemented along the
way as well.
Although gene-environment interac-
tions may prove to be more complicated
than what the Environmental Genome
Project can initially or alone unravel, "it's
the next logical step to better identify and
protect susceptible populations," Taylor
says.
Olden estimates that the cost to
sequence the "environmental" genes in
1,000 people will be about $60 million,
and he has already committed $10 million
from the NIEHS's 1998 budget to the
plan. "It's a project we can afford," says
Olden, who hopes additional funds will
come from other branches ofthe National
Institutes of Health, including the
National Cancer Institute and the
National Human Genome Research
Institute. "We'd like to see every institute
involved in some way," Olden says. "This
is one of the most important databases to
have."
JulieWakefieldAlbers
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